Siaton, Nimfa .
HRN: 18-65-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2023
CEFUROXIME 500MG (TAB)
03/18/2023
03/25/2023
ORAL
500mg
BID
S/P LTCS
Waiting Final Action
03/18/2023
METRONIDAZOLE 500MG (TAB)
03/18/2023
03/25/2023
ORAL
500mg
TID
S/P LTCS
Waiting Final Action